# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541619 | metabolite_detected | Homo sapiens | |||||
2. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541620 | metabolite_detected | Rattus norvegicus | |||||
3. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541621 | metabolite_detected | Homo sapiens | |||||
4. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541622 | metabolite_detected | Rattus norvegicus | |||||
5. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | PB | 0 | ALA3541635 | Active | % | |||||
6. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 1.5 | % | ALA3539501 | % | ||||
7. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 0.3 | % | ALA3539500 | % | ||||
8. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 0.06 | % | ALA3539506 | % | ||||
9. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541623 | metabolite_detected | Homo sapiens | |||||
10. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541624 | metabolite_detected | Rattus norvegicus | |||||
11. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541625 | metabolite_detected | Homo sapiens | |||||
12. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541626 | metabolite_detected | Rattus norvegicus | |||||
13. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541627 | metabolite_detected | Homo sapiens | |||||
14. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541628 | metabolite_detected | Rattus norvegicus | |||||
15. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541629 | metabolite_detected | Homo sapiens | |||||
16. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541630 | metabolite_detected | Rattus norvegicus | |||||
17. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541631 | metabolite_detected | Homo sapiens | |||||
18. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541632 | metabolite_detected | Rattus norvegicus | |||||
19. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Retention_time | = | 12.8 | min | ALA3541615 | min | Homo sapiens | |||
20. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Retention_time | = | 12.8 | min | ALA3541616 | min | Rattus norvegicus |